Previous close | 7.69 |
Open | 7.59 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's range | 7.19 - 7.69 |
52-week range | 5.43 - 29.81 |
Volume | |
Avg. volume | 925,534 |
Market cap | 2.729B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.07 |
Earnings date | 09 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 10.00 |
Joining me today are Mike Lester, chief executive officer; Mike Bruff, chief financial officer; and Danish Qureshi, chief growth officer. Both are available on the Investor Relations section of our website, investor.lifestance.com.
Image source: The Motley Fool. LifeStance Health Group, Inc. (NASDAQ: LFST)Q4 2021 Earnings CallMar 10, 2022, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and thank you for standing by.
NEW YORK, November 18, 2021--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against LifeStance Health Group ("LifeStance" or the "Company") (NASDAQ: LFST) on behalf of LifeStance stockholders. Our investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices.